Protocol Number: 08-CC-0127

Title:

Communicating a Cancer Diagnosis: Current Methods and Their Effects

Number:

08-CC-0127

Summary:

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will:

-Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.

-Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.

-Identify who informs the patient of their diagnosis..

-Determine patient satisfaction with their diagnostic consult.

-Identify indicators of satisfaction with the diagnostic consultation.

Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.

Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.

Sponsoring Institute:

National Institutes of Health Clinical Center (CC)

Recruitment Detail

Type: Participants currently recruited/enrolled

Gender: Male & Female

Referral Letter Required: No

Population Exclusion(s): Children

Eligibility Criteria:

INCLUSION CRITERIA:

1. Age greater than or equal to 18 years.

2. A patient diagnosed with cancer who is either currently enrolled in a protocol and receiving treatment or has come to NCI for consult and potential enrollment in a trial.

3. Ability to follow basic verbal instructions as observed by either an investigator of the study or as reported by a member of the patient's primary clinical team.

4. Patient must comprehend English, verbal and written, to be determined by the investigator distributing the questionnaire.

-Patients with a hearing and/or visual impairment will be eligible to participate in the study if they so choose. Appropriate accommodations will be made.

5. Signed informed consent form.

EXCLUSION CRITERIA:

1. Patients that have cognitive impairments, such as mental challenges/retardation due to a congenital or developmental anomaly.

a. Subjects with cognitive impairments are ineligible to participate in the study due to comprehension inabilities.

2. Patients who have developed dementia as a result of their disease or from an unspecified source are not eligible for participation due to both memory and overall cognitive deficits.

3. Patients that have multiple concurrent cancers are excluded from participation in this study.

Special Instructions:

Currently Not Provided

Keywords:

Communicating a Diagnosis

Cancer Diagnosis

Recurrence of Cancer

Initial Cancer Diagnosis

Recruitment Keyword(s):

Cancer Diagnosis

Recurrence of Cancer

Condition(s):

Behavior

Cancer

Investigational Drug(s):

None

Investigational Device(s):

None

Intervention(s):

None

Supporting Site:

Warren G. Magnuson Clinical Center

Contact(s):

Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

Electronic Mail:prpl@mail.cc.nih.gov

Citation(s):

Maguire P, Pitceathly C. Key communication skills and how to acquire them. BMJ. 2002 Sep 28;325(7366):697-700. Review.

Zachariae R, Pedersen CG, Jensen AB, Ehrnrooth E, Rossen PB, von der Maase H. Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease.Br J Cancer. 2003 Mar 10;88(5):658-65.

Barnett MM. Does it hurt to know the worst?--psychological morbidity, information preferences and understanding of prognosis in patients with advanced cancer. Psychooncology. 2006 Jan;15(1):44-55.

• Questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
• Technical questions regarding the Clinical Center web site, please contact the Department of Clinical Research Informatics, CC.

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

National Institutes of Health Clinical Center Bethesda, Maryland 20892. Last update: 01/30/2009